arrow
W

William G. Powderly

Washington University School of Medicine
H指数:82
被引数:2.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

SARS-CoV-2 N protein and anti-spike serologies: insights into COVID-19 disease severity and mortality-a secondary analysis of the ACTIV-1 trial

SARS-CoV-2 N蛋白和抗刺突蛋白血清学:对COVID-19疾病严重程度和死亡率的见解——ACTIV-1试验的二次分析

2025-04-220
OA
Position of the Infectious Diseases Society of America and the HIV Medicine Association on Team-based Infectious Diseases Care and the Roles of Advanced Practice Providers and Clinical Pharmacists
2024-05-275
OA
Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19 A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial

新型冠状病毒肺炎住院患者的阿巴西普药代动力学和暴露反应ACTIV-1 IM随机临床试验的二次分析

2024-04-251
OAAI
The STOP COVID 2 Study: Fluvoxamine vs Placebo for Outpatients With Symptomatic COVID-19, a Fully Remote Randomized Controlled Trial

STOP COVID 2研究: 氟伏沙明与安慰剂治疗有症状新型冠状病毒肺炎的门诊患者,一项完全远程随机对照试验

2023-08-0810
OAAI
Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia A Randomized Clinical Trial

Abatacept,Cenicriviroc或英夫利昔单抗治疗COVID-19肺炎住院成人的随机临床试验

2023-07-2535
OA